
### [MONDO:0020152](http://purl.obolibrary.org/obo/MONDO_0020152)
**Label:** eyelid malformation

**Subclasses:** [MONDO:0008182](http://purl.obolibrary.org/obo/MONDO_0008182) (Nasopalpebral lipoma-coloboma syndrome), [MONDO:0007508](http://purl.obolibrary.org/obo/MONDO_0007508) (Rapp-Hodgkin syndrome), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0007943](http://purl.obolibrary.org/obo/MONDO_0007943) (Nager acrofacial dysostosis), [MONDO:0020360](http://purl.obolibrary.org/obo/MONDO_0020360) (complete cryptophthalmia), [MONDO:0020361](http://purl.obolibrary.org/obo/MONDO_0020361) (partial cryptophthalmia), [MONDO:0007124](http://purl.obolibrary.org/obo/MONDO_0007124) (ankyloblepharon-ectodermal defects-cleft lip/palate syndrome), [MONDO:0007123](http://purl.obolibrary.org/obo/MONDO_0007123) (ankyloblepharon filiforme adnatum-cleft palate syndrome), [MONDO:0015201](http://purl.obolibrary.org/obo/MONDO_0015201) (ankyloblepharon filiforme-imperforate anus syndrome), [MONDO:0019626](http://purl.obolibrary.org/obo/MONDO_0019626) (isolated ankyloblepharon filiforme adnatum), [MONDO:0008693](http://purl.obolibrary.org/obo/MONDO_0008693) (ablepharon macrostomia syndrome), [MONDO:0009046](http://purl.obolibrary.org/obo/MONDO_0009046) (Fraser syndrome), [MONDO:0008112](http://purl.obolibrary.org/obo/MONDO_0008112) (Goldenhar syndrome), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0020155](http://purl.obolibrary.org/obo/MONDO_0020155) (eyelid border anomaly), [MONDO:0020156](http://purl.obolibrary.org/obo/MONDO_0020156) (syndromic ankyloblepharon), [MONDO:0009148](http://purl.obolibrary.org/obo/MONDO_0009148) (Rosselli-Gulienetti syndrome), [MONDO:0009247](http://purl.obolibrary.org/obo/MONDO_0009247) (Frontofacionasal dysplasia), [MONDO:0020157](http://purl.obolibrary.org/obo/MONDO_0020157) (syndromic palpebral coloboma), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), [MONDO:0020357](http://purl.obolibrary.org/obo/MONDO_0020357) (coloboma of eyelid), [MONDO:0020359](http://purl.obolibrary.org/obo/MONDO_0020359) (congenital symblepharon), [MONDO:0009903](http://purl.obolibrary.org/obo/MONDO_0009903) (postaxial acrofacial dysostosis), [MONDO:0007334](http://purl.obolibrary.org/obo/MONDO_0007334) (autosomal dominant popliteal pterygium syndrome), [MONDO:0020153](http://purl.obolibrary.org/obo/MONDO_0020153) (cryptophthalmia), [MONDO:0007410](http://purl.obolibrary.org/obo/MONDO_0007410) (isolated cryptophthalmia), [MONDO:0020154](http://purl.obolibrary.org/obo/MONDO_0020154) (Microblepharon-ablephara syndrome), 

**Mapped go classes:** [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0007499](http://purl.obolibrary.org/obo/GO_0007499) (ectoderm and mesoderm interaction), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0051402](http://purl.obolibrary.org/obo/GO_0051402) (neuron apoptotic process), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0048807](http://purl.obolibrary.org/obo/GO_0048807) (female genitalia morphogenesis), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0003338](http://purl.obolibrary.org/obo/GO_0003338) (metanephros morphogenesis), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0010669](http://purl.obolibrary.org/obo/GO_0010669) (epithelial structure maintenance), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:2000381](http://purl.obolibrary.org/obo/GO_2000381) (negative regulation of mesoderm development), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0071711](http://purl.obolibrary.org/obo/GO_0071711) (basement membrane organization), [GO:0035259](http://purl.obolibrary.org/obo/GO_0035259) (glucocorticoid receptor binding), [GO:0050699](http://purl.obolibrary.org/obo/GO_0050699) (WW domain binding), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:2000271](http://purl.obolibrary.org/obo/GO_2000271) (positive regulation of fibroblast apoptotic process), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0045617](http://purl.obolibrary.org/obo/GO_0045617) (negative regulation of keratinocyte differentiation), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0009913](http://purl.obolibrary.org/obo/GO_0009913) (epidermal cell differentiation), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0030859](http://purl.obolibrary.org/obo/GO_0030859) (polarized epithelial cell differentiation), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0030850](http://purl.obolibrary.org/obo/GO_0030850) (prostate gland development), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0045747](http://purl.obolibrary.org/obo/GO_0045747) (positive regulation of Notch signaling pathway), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0001738](http://purl.obolibrary.org/obo/GO_0001738) (morphogenesis of a polarized epithelium), [GO:0030159](http://purl.obolibrary.org/obo/GO_0030159) (receptor signaling complex scaffold activity), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0097371](http://purl.obolibrary.org/obo/GO_0097371) (MDM2/MDM4 family protein binding), [GO:0001302](http://purl.obolibrary.org/obo/GO_0001302) (replicative cell aging), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0060529](http://purl.obolibrary.org/obo/GO_0060529) (squamous basal epithelial stem cell differentiation involved in prostate gland acinus development), [GO:0061618](http://purl.obolibrary.org/obo/GO_0061618) (sublamina densa), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0010259](http://purl.obolibrary.org/obo/GO_0010259) (multicellular organism aging), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0060197](http://purl.obolibrary.org/obo/GO_0060197) (cloacal septation), [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0060513](http://purl.obolibrary.org/obo/GO_0060513) (prostatic bud formation), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0010482](http://purl.obolibrary.org/obo/GO_0010482) (regulation of epidermal cell division), [GO:0010481](http://purl.obolibrary.org/obo/GO_0010481) (epidermal cell division), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0098773](http://purl.obolibrary.org/obo/GO_0098773) (skin epidermis development), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0060157](http://purl.obolibrary.org/obo/GO_0060157) (urinary bladder development), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:1904674](http://purl.obolibrary.org/obo/GO_1904674) (positive regulation of somatic stem cell population maintenance), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process), [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), 

**Class expressions from DL-Learner:**

- Thing 55.39%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.70%
- [GO:0061618](http://purl.obolibrary.org/obo/GO_0061618) (sublamina densa) 50.70%
- [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane) 50.70%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.45%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.06%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005644](http://purl.obolibrary.org/obo/GO_0005644) (null)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005636](http://purl.obolibrary.org/obo/GO_0005636) (null)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005627](http://purl.obolibrary.org/obo/GO_0005627) (obsolete ascus)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005626](http://purl.obolibrary.org/obo/GO_0005626) (obsolete insoluble fraction)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005625](http://purl.obolibrary.org/obo/GO_0005625) (obsolete soluble fraction)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005624](http://purl.obolibrary.org/obo/GO_0005624) (obsolete membrane fraction)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005620](http://purl.obolibrary.org/obo/GO_0005620) (null)) 36.06%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005617](http://purl.obolibrary.org/obo/GO_0005617) (obsolete larval serum protein-1)) 36.06%


